Radiance Medical Systems develops site-specific delivery
catheters for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.
The ATRIGEL technology was initially developed for local site-specific delivery
of an antibiotic for the treatment of periodontal disease.
The SynBiosys drug delivery platform is based on novel biodegradable multi-block co-polymers with unique molecular architectures that allow precise and site-specific delivery
of drugs for predetermined periods of time, ranging from weeks to many months.
is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery
of therapeutic agents for applications in hypertension, cardiovascular disease, pulmonary, oncology and regenerative medicine.
Pioneering new treatment category - site-specific delivery
of drugs to the brain